BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: BTX 1801 Phase 2a Antimicrobial Study Underway, page-175

  1. 24 Posts.
    lightbulb Created with Sketch. 6
    Am a bit new on BOT - after reading the University in Canada published paper the BTX1801 confidences this Cannabinoid approach seems fairly strong. Is the perception here that BOT has burnt investors before and now have trust issues? is it some bigger power holding the price down?
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.